KRAS p, G12c Mutated /Advanced Metastatic NSCLC research hub

Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).

This study compares a new medicine, AMG 510 (also called Sotorasib), with a standard chemotherapy, Docetaxel, for people with a specific type of lung cancer. It's for advanced non-small cell lung cancer that has a particular genetic change called KRAS G12C and has already been treated.